With decades of practical formulation development experience and a keen attention to detail, we create injectable formulations that are safe and efficacious. Our development process produces optimal drug product formulations with strategies that withstand FDA scrutiny and accelerate successful commercialization. With the Design of Experiments (DOE) approach, we assess samples under accelerated stress conditions and use these insights to select the most stable formulations.
Targeted drug delivery often involves subcutaneous, intramuscular, or intravenous routes of administration. To select the most appropriate delivery method, our team helps evaluate key therapeutic stability constraints, such as volume, pH, osmolality, and viscosity. We also support injection site selection for effective drug substance absorption. Our comprehensive formulation development ensures accurate dosing and limits immunogenicity concerns to achieve optimal drug delivery.
FIND ADDITIONAL EARLY PHASE SERVICES
